Since the COVID-19 pandemic, dermatology clinicians have been inundated with questions beyond the infection itself. On one hand, the pandemic had a profound global impact on medical practice and patient behaviours, which could affect the diagnosis, treatment and prognosis of dermatological patients. On the other hand, patients with skin diseases usually had multi-comorbidities including hypertension, cardiovascular disease, diabetes and obesity, which are closely associated with the clinical severity of COVID-19. Therefore, clinicians have been facing difficulties regarding the management of patients with COVID-19 and skin diseases.
A variety of vaccines with different technologies have been developed to control the devastating pandemic. However, vaccines can cause some skin diseases including dermatomyositis. Vaccinated dermatomyositis patients had exacerbation of autoimmune signs and symptoms after the vaccine. Therefore, it is of great significance to clarify the impact of the COVID-19 vaccines on the diagnosis, treatment and outcomes of dermatological patients.
This Research Topic aims at clarifying the impact of the COVID-19 pandemic on the diagnosis, treatment and outcomes of dermatology patients. These findings will guide current recommendations and provide a reference for clinical decision-making. The spectrum of skin diseases includes, but is not limited to:
? Skin cancers
? Psoriasis
? Herpes zoster
? Dermatitis medicamentosa
? Eczema, dermatitis, prurigo
? Urticaria
? Bullous diseases
? Acne conglobate
? Infectious skin diseases
Since the COVID-19 pandemic, dermatology clinicians have been inundated with questions beyond the infection itself. On one hand, the pandemic had a profound global impact on medical practice and patient behaviours, which could affect the diagnosis, treatment and prognosis of dermatological patients. On the other hand, patients with skin diseases usually had multi-comorbidities including hypertension, cardiovascular disease, diabetes and obesity, which are closely associated with the clinical severity of COVID-19. Therefore, clinicians have been facing difficulties regarding the management of patients with COVID-19 and skin diseases.
A variety of vaccines with different technologies have been developed to control the devastating pandemic. However, vaccines can cause some skin diseases including dermatomyositis. Vaccinated dermatomyositis patients had exacerbation of autoimmune signs and symptoms after the vaccine. Therefore, it is of great significance to clarify the impact of the COVID-19 vaccines on the diagnosis, treatment and outcomes of dermatological patients.
This Research Topic aims at clarifying the impact of the COVID-19 pandemic on the diagnosis, treatment and outcomes of dermatology patients. These findings will guide current recommendations and provide a reference for clinical decision-making. The spectrum of skin diseases includes, but is not limited to:
? Skin cancers
? Psoriasis
? Herpes zoster
? Dermatitis medicamentosa
? Eczema, dermatitis, prurigo
? Urticaria
? Bullous diseases
? Acne conglobate
? Infectious skin diseases
